Opportunity timeline
In plain English
ARPA-H is seeking innovative solutions for a near-real-time, non-destructive, AI-enabled system to screen pharmaceutical products and inputs through their packaging. The system would be used at ports of entry and other supply-chain locations. Interested parties should review the FASTPASS Innovative Solutions Opening, ARPA-H-SOL-26-160.
About this opportunity
The Advanced Research Projects Agency for Health (ARPA-H) Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) program aims to develop a near real-time, non-destructive, AI-enabled system for screening pharmaceutical products and inputs through their packaging at ports of entry and other supply-chain nodes. Interested parties are invited to review the attached FASTPASS Innovative Solutions Opening, ARPA-H-SOL-26-160.
Time remaining
Closes Nov 10, 2026
Related Opportunities

Illumina DRAGEN Tier 3 Throughput License and v4 Server

Emergent Drug Panel-Version 2 (EDP-V2) Kit

Medicinal Chemistry Support Program for Therapeutic Development (MCSP)

Medicinal Chemistry Support Program for Therapeutic Development (MCSP)

Health Advisory Committees Research and Support
Bid details are gathered and summarized automatically. Please verify details at the original source.
Ref No.
BS-636AAF

